#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gestational trophoblastic tumour Sickle cell anaemia Undifferentiated sarcoma Type IIa hyperlipidaemia Malignant neoplasm of choroid Fallopian tube cancer Progressive familial intrahepatic cholestasis Antiphospholipid antibodies Familial amyotrophic lateral sclerosis Propionic acidaemia Cortical dysplasia Palmoplantar pustulosis Philadelphia positive acute lymphocytic leukaemia Hyperphagia Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Treatment Rhabdoid tumour – Trials in Disease Hereditary angioedema – Diagnostics Synovial sarcoma metastatic – Life with Disease Osteosarcoma – Treatment Cerebral arteriovenous malformation haemorrhagic – Treatment Andersen-Tawil syndrome – Basic Information Small intestine leiomyosarcoma – Life with Disease Atypical haemolytic uraemic syndrome – Trials in Disease Lennox-Gastaut syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tamoxifen Citrate Bp1.7881A Cefazolin Sodium Lansoprazole Metreleptin Sodium Fluoride (18F) Cloxacillin Urea Ferric Derisomaltose Rbl035.2 Ovolecithin Intestifix Tropicamide Degarelix Quemliclustat Potassium Oxybate Lenograstim Deucrictibant Paroxetine Insulin Human More therapies…

    Learn about Your Condition

    Inclusion body myositis Adrenogenital syndrome Haemorrhage Cerebellar ataxia Cholangiosarcoma Bronchostenosis Lichen planopilaris Respiratory failure Depression Hyperchylomicronaemia Osteochondrodysplasia Bile duct adenocarcinoma Loeys-Dietz syndrome Chronic myeloid leukaemia Hereditary optic atrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Haga Hospital

Haga Hospital

Els Borst-Eilersplein 275, Hague, 2545 AA, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    • Dizziness
    • Ear discomfort
    Investigated Drugs:
    • Dexamethasone
    • Gentamicin
    • Methylprednisolone
    The Netherlands

  • Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +4

  • Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +5

  • Study on Docetaxel, Cabazitaxel, and Darolutamide for Men with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Darolutamide
    • Docetaxel
    The Netherlands

  • Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Austria Bulgaria Czechia France Germany Greece +8

  • Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Bulgaria Czechia Denmark France +14

  • Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Adagrasib
    • Pembrolizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Docetaxel
    • Telisotuzumab Vedotin
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Crd-4730
    Bulgaria Czechia Hungary Italy Latvia Lithuania +4

  • Rituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Venetoclax
    The Netherlands
Previous Page
1 … 4 5 6 7 8 … 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!